{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:56:50Z","timestamp":1794265010256,"version":"4.9.0"},"reference-count":260,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK127761"],"award-info":[{"award-number":["DK127761"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.molmet.2021.101325","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T10:37:35Z","timestamp":1629542255000},"page":"101325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Structural principles of insulin formulation and analog design: A century of innovation"],"prefix":"10.1016","volume":"52","author":[{"given":"Mark A.","family":"Jarosinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Dhayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Varas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2021.101325_bib1","series-title":"The discovery of insulin","author":"Bliss","year":"2019"},{"key":"10.1016\/j.molmet.2021.101325_bib2","doi-asserted-by":"crossref","first-page":"101194","DOI":"10.1016\/j.molmet.2021.101194","article-title":"Insulin: a pacesetter for the shape of modern biomedical science and the nobel prize","author":"Flier","year":"2021","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.molmet.2021.101325_bib3","series-title":"Insulin preparations. Galenics of insulin","first-page":"17","author":"Brange","year":"1987"},{"issue":"11","key":"10.1016\/j.molmet.2021.101325_bib4","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1023\/A:1013057825942","article-title":"Diamonds in the rough: protein crystals from a formulation perspective","volume":"18","author":"Jen","year":"2001","journal-title":"Pharmaceutical Research"},{"issue":"1195","key":"10.1016\/j.molmet.2021.101325_bib5","first-page":"369","article-title":"The structure of 2-Zn pig insulin crystals at 1.5 \u00c5 resolution","volume":"319","author":"Baker","year":"1988","journal-title":"Philosophical Transactions of the Royal Society B"},{"issue":"5218","key":"10.1016\/j.molmet.2021.101325_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/224491a0","article-title":"Structure of rhombohedral 2 zinc insulin crystals","volume":"224","author":"Adams","year":"1969","journal-title":"Nature"},{"issue":"5304","key":"10.1016\/j.molmet.2021.101325_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/231506a0","article-title":"X-ray analysis and the structure of insulin","volume":"231","author":"Blundell","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2021.101325_bib8","series-title":"Peking Review","first-page":"11","volume":"40","year":"1971"},{"key":"10.1016\/j.molmet.2021.101325_bib9","series-title":"Scientia Sinica","first-page":"752","volume":"17","year":"1975"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0968-0004(98)01313-9","article-title":"The insulin connection: dorothy Hodgkin and the Beijing insulin group","volume":"23","author":"Wang","year":"1998","journal-title":"Trends in Biochemical Sciences"},{"issue":"22","key":"10.1016\/j.molmet.2021.101325_bib11","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/bi00236a025","article-title":"Comparative 2D NMR studies of human insulin and despentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition","volume":"30","author":"Hua","year":"1991","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-1033.1991.tb16394.x","article-title":"The solution structure of a monomeric insulin: a two-dimensional 1H-NMR study of des-(B26\u2013B30)-insulin in combination with distance geometry and restrained molecular dynamics","volume":"202","author":"Knegtel","year":"1991","journal-title":"European Journal of Biochemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00178342","article-title":"A\u00a0new 2D NMR method for measurement of JHH coupling constants","volume":"4","author":"S\u00f8rensen","year":"1994","journal-title":"Journal of Biomolecular NMR"},{"issue":"27","key":"10.1016\/j.molmet.2021.101325_bib14","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1021\/bi960292+","article-title":"Solution structure of an engineered insulin monomer at neutral pH","volume":"35","author":"Olsen","year":"1996","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/jmbi.1996.0239","article-title":"Structure and dynamics of a protein assembly. 1H-NMR studies of the 36 kDa R6 insulin hexamer","volume":"258","author":"Jacoby","year":"1996","journal-title":"Journal of Molecular Biology"},{"issue":"21","key":"10.1016\/j.molmet.2021.101325_bib16","doi-asserted-by":"crossref","first-page":"14586","DOI":"10.1074\/jbc.M900085200","article-title":"Enhancing the activity of a protein by stereospecific unfolding: conformational life cycle OF insulin and its evolutionary origins","volume":"284","author":"Hua","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2021.101325_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fendo.2011.00048","article-title":"Conformational dynamics of insulin","volume":"2","author":"Hua","year":"2011","journal-title":"Frontiers in Endocrinology"},{"issue":"7699","key":"10.1016\/j.molmet.2021.101325_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature26153","article-title":"Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis","volume":"556","author":"Scapin","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06826-6","article-title":"The signalling conformation of the insulin receptor ectodomain","volume":"9","author":"Weis","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.molmet.2021.101325_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48630","article-title":"Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex","volume":"8","author":"Uchikawa","year":"2019","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib21","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201907210","article-title":"Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain","volume":"219","author":"Gutmann","year":"2020","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.molmet.2021.101325_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101255","article-title":"Understanding insulin and its receptor from their three-dimensional structure","author":"Lawrence","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"Supplement 1","key":"10.1016\/j.molmet.2021.101325_bib23","first-page":"S211","article-title":"Diabetes care in the hospital: standards of medical care in diabetes","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrd.2015.36","article-title":"Pursuit of a perfect insulin","volume":"15","author":"Zaykov","year":"2016","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.molmet.2021.101325_bib25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00125-021-05422-6","article-title":"\u2018Smart\u2019 insulin-delivery technologies and intrinsic glucose-responsive insulin analogues","author":"Jarosinski","year":"2021","journal-title":"Diabetologia"},{"issue":"25","key":"10.1016\/j.molmet.2021.101325_bib26","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"vol. 353","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2021.101325_bib27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2337\/dc18-1613","article-title":"Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT\/EDIC study","volume":"42","author":"Bebu","year":"2019","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib28","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.2337\/db06-0653","article-title":"The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study","volume":"55","author":"Cleary","year":"2006","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00125-021-05397-4","article-title":"Realising the long-term promise of insulin therapy: the DCCT\/EDIC study","volume":"64","author":"Nathan","year":"2021","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1172\/JCI113339","article-title":"Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects","volume":"81","author":"Polonsky","year":"1988","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2337\/diacare.14.9.824","article-title":"Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects","volume":"14","author":"Nuttall","year":"1991","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib32","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/diacare.27.9.2266","article-title":"Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association","volume":"27","author":"Sheard","year":"2004","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2337\/diacare.3.5.623","article-title":"Intermediate-acting insulin preparations: NPH and lente","volume":"3","author":"Deckert","year":"1980","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-3565(25)09793-9","article-title":"Studies on insulin with protamine","volume":"58","author":"Scott","year":"1936","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejps.2007.01.003","article-title":"Structural characterization of insulin NPH formulations","volume":"30","author":"Norrman","year":"2007","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s13300-019-0619-1","article-title":"A\u00a0view beyond HbA1c: role of continuous glucose monitoring","volume":"10","author":"Chehregosha","year":"2019","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.molmet.2021.101325_bib37","article-title":"Finger-stick glucose monitoring: issues of accuracy and specificity","author":"Olansky","year":"2010","journal-title":"American Diabetes Association"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bst0210609","article-title":"Molecular recognition in insulin assembly","volume":"21","author":"Dodson","year":"1993","journal-title":"Biochemical Society Transactions"},{"issue":"s1","key":"10.1016\/j.molmet.2021.101325_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/dom.12068","article-title":"Newer insulin analogs: advances in basal insulin replacement","volume":"15","author":"Zinman","year":"2013","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/dia.2020.0180","article-title":"Comparison of second-generation basal insulin analogs: a review of the evidence from continuous glucose monitoring","volume":"23","author":"Battelino","year":"2021","journal-title":"Diabetes Technology & Therapeutics"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib41","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/s001250051400","article-title":"The new era of biotech insulin analogues","volume":"40","author":"Brange","year":"1997","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1012095115151","article-title":"Assembly and dissociation of human insulin and LysB28, ProB29-insulin hexamers: a comparison study","volume":"14","author":"Birnbaum","year":"1997","journal-title":"Pharmaceutical Research"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib43","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/dia.2020.0065","article-title":"Recent advances in insulin therapy","volume":"22","author":"Wilson","year":"2020","journal-title":"Diabetes Technology & Therapeutics"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1042\/bj0600556","article-title":"The structure of pig and sheep insulins","volume":"60","author":"Brown","year":"1955","journal-title":"Biochemical Journal"},{"issue":"3359","key":"10.1016\/j.molmet.2021.101325_bib45","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.129.3359.1340","article-title":"Chemistry of insulin","volume":"129","author":"Sanger","year":"1959","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/genetics\/162.2.527","article-title":"The first sequence: fred Sanger and insulin","volume":"162","author":"Stretton","year":"2002","journal-title":"Genetics"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1073\/pnas.12.2.132","article-title":"Crystalline insulin","volume":"12","author":"Abel","year":"1926","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib48","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1042\/bj0281592","article-title":"Crystalline insulin","volume":"28","author":"Scott","year":"1934","journal-title":"Biochemical Journal"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142239","article-title":"The discovery of insulin revisited: lessons for the modern era","volume":"131","author":"Lewis","year":"2021","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib50","first-page":"1598","article-title":"The story of insulin crystallography","volume":"83","author":"Vijayan","year":"2002","journal-title":"Current Science"},{"key":"10.1016\/j.molmet.2021.101325_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/135591a0","article-title":"X-ray single-crystal photographs of insulin","volume":"135","author":"Crowfoot","year":"1935","journal-title":"Nature"},{"issue":"3569","key":"10.1016\/j.molmet.2021.101325_bib52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.140.3569.863","article-title":"X-ray analysis of hemoglobin","volume":"140","author":"Perutz","year":"1963","journal-title":"Science"},{"issue":"3561","key":"10.1016\/j.molmet.2021.101325_bib53","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1126\/science.139.3561.1259","article-title":"Myoglobin and the structure of proteins","volume":"139","author":"Kendrew","year":"1963","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib54","doi-asserted-by":"crossref","first-page":"50P","DOI":"10.1042\/bj1250050P","article-title":"The structure and biology of insulin","volume":"125","author":"Blundell","year":"1971","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.molmet.2021.101325_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0065-3233(08)60143-6","article-title":"Insulin: the structure in the crystal and its reflection in chemistry and biology by","volume":"26","author":"Blundell","year":"1972","journal-title":"Advances in Protein Chemistry"},{"issue":"5908","key":"10.1016\/j.molmet.2021.101325_bib56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/302500a0","article-title":"Transmission of conformational change in insulin","volume":"302","author":"Chothia","year":"1983","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.bi.53.070184.002541","article-title":"Principles that determine the structure of proteins","volume":"53","author":"Chothia","year":"1984","journal-title":"Annual Review of Biochemistry"},{"issue":"5504","key":"10.1016\/j.molmet.2021.101325_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/255103a0","article-title":"Chinese work on insulin","volume":"255","author":"Hodgkin","year":"1975","journal-title":"Nature"},{"issue":"5304","key":"10.1016\/j.molmet.2021.101325_bib59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/231506a0","article-title":"Atomic positions in rhombohedral 2-zinc insulin crystals","volume":"231","author":"Blundell","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2021.101325_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annual Review of Biochemistry"},{"issue":"2143","key":"10.1016\/j.molmet.2021.101325_bib61","doi-asserted-by":"crossref","first-page":"20180214","DOI":"10.1098\/rsta.2018.0214","article-title":"On the theory of crystal growth in metastable systems with biomedical applications: protein and insulin crystallization","volume":"377","author":"Alexandrov","year":"2019","journal-title":"Philosophical Transactions of the Royal Society A"},{"issue":"14","key":"10.1016\/j.molmet.2021.101325_bib62","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1073\/pnas.142459399","article-title":"The protofilament structure of insulin amyloid fibrils","volume":"99","author":"Jimenez","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2007-8-9-227","article-title":"The protamine family of sperm nuclear proteins","volume":"8","author":"Balhorn","year":"2007","journal-title":"Genome Biology"},{"issue":"3015","key":"10.1016\/j.molmet.2021.101325_bib64","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1126\/science.116.3015.394","article-title":"Crystalline and amorphous insulin-zinc compounds with prolonged action","volume":"116","author":"Hallas-M\u00f8ller","year":"1952","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diab.5.1.7","article-title":"The lente insulins","volume":"5","author":"Hallas-M\u00f8","year":"1956","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib66","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/prot.22213","article-title":"Crystal structure of Ultralente\u2014a microcrystalline insulin suspension","volume":"74","author":"Wagner","year":"2009","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"issue":"6216","key":"10.1016\/j.molmet.2021.101325_bib67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/338594a0","article-title":"Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer","volume":"338","author":"Derewenda","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2021.101325_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0968-0004(91)90140-Q","article-title":"Insulin hexamers: new conformations and applications","volume":"16","author":"Brader","year":"1991","journal-title":"Trends in Biochemical Sciences"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib69","doi-asserted-by":"crossref","first-page":"100484","DOI":"10.1016\/j.pcrysgrow.2020.100484","article-title":"Advancements (and challenges) in the study of protein crystal nucleation and growth; thermodynamic and kinetic explanations and comparison with small-molecule crystallization","volume":"66","author":"Nanev","year":"2020","journal-title":"Progress in Crystal Growth and Characterization of Materials"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.1936.02770030007002","article-title":"Protamine insulinate","volume":"106","author":"Hagedorn","year":"1936","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.molmet.2021.101325_bib71","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/003591573703000643","article-title":"Protamine insulinate","volume":"30","author":"Hagedorn","year":"1937","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cber.187400701119","article-title":"Das Protamin, eine neue organische Base aus den Samenf\u00e4den des Rheinlachses","volume":"7","author":"Miescher","year":"1874","journal-title":"Berichte der Deutschen Chemischen Gesellschaft"},{"key":"10.1016\/j.molmet.2021.101325_bib73","series-title":"\u00dcber Protamine und Histone","first-page":"301","author":"Kossel","year":"1906"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib74","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF03045166","article-title":"The physiological effects of protamines and their cleavage products","volume":"18","author":"Thompson","year":"1900","journal-title":"Transactions of the Royal Academy of Medicine in Ireland"},{"key":"10.1016\/j.molmet.2021.101325_bib75","series-title":"The 150th anniversary of the discovery of DNA. Biomics","author":"Byrne","year":"2019"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/1046-5928(90)90005-J","article-title":"Purification and analysis of the major components of chum salmon protamine contained in insulin formulations using high-performance liquid chromatography","volume":"1","author":"Hoffmann","year":"1990","journal-title":"Protein Expression and Purification"},{"key":"10.1016\/j.molmet.2021.101325_bib77","first-page":"60","article-title":"Crystalline protamine insulin","volume":"1","author":"Krayenbuhl","year":"1946","journal-title":"Rep Steno Mem Hosp Nord Insulinlab"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib78","first-page":"1","article-title":"Insulin preparations","volume":"73","author":"Fisher","year":"1955","journal-title":"Canadian Medical Association Journal"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib79","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF01219531","article-title":"The clinical significance of highly purified pig-insulin preparations","volume":"10","author":"Deckert","year":"1974","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.molmet.2021.101325_bib80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.2042-7158.1984.tb04418.x","article-title":"An in-vitro test for the duration of action of insulin suspensions","volume":"36","author":"Graham","year":"1984","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.molmet.2021.101325_bib81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2015.07.016","article-title":"A\u00a0novel in\u00a0vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components","volume":"214","author":"Kinnunen","year":"2015","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.molmet.2021.101325_bib82","doi-asserted-by":"crossref","first-page":"105239","DOI":"10.1016\/j.ejps.2020.105239","article-title":"Towards in\u00a0vitro in\u00a0vivo correlation for modified release subcutaneously administered insulins","volume":"145","author":"Bock","year":"2020","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib83","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF00276967","article-title":"Absorption kinetics and action profiles of mixtures of short-and intermediate-acting insulins","volume":"27","author":"Heine","year":"1984","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib84","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/diacare.17.5.366","article-title":"Comparative pharmacokinetics and glucodynamics of two human insulin mixtures 70\/30 and 50\/50 insulin mixtures","volume":"17","author":"Woodworth","year":"1994","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib85","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1107\/S010876819100842X","article-title":"Structure of porcine insulin cocrystallized with clupeine Z","volume":"47","author":"Balschmidt","year":"1991","journal-title":"Acta Crystallographica Section B Structural Science"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF00253194","article-title":"Circulating IgG antibody to protamine in patients treated with protamine-insulins","volume":"25","author":"Kurtz","year":"1983","journal-title":"Diabetologia"},{"issue":"Supplement 3","key":"10.1016\/j.molmet.2021.101325_bib87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.16.3.155","article-title":"Immunogenicity and allergenic potential of animal and human insulins","volume":"16","author":"Schernthaner","year":"1993","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/protein\/1.3.215","article-title":"Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30","volume":"1","author":"Markussen","year":"1987","journal-title":"Protein Engineering Design and Selection"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/protein\/2.2.157","article-title":"Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30","volume":"2","author":"Markussen","year":"1988","journal-title":"Protein Engineering Design and Selection"},{"issue":"6696","key":"10.1016\/j.molmet.2021.101325_bib90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/bmj.299.6696.415","article-title":"NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue","volume":"299","author":"J\u00f8rgensen","year":"1989","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/diacare.5.1.25","article-title":"Electron microscopy of insulin precipitates","volume":"5","author":"Schade","year":"1982","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib92","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1345\/aph.1A301","article-title":"Insulin glargine: a new basal insulin","volume":"36","author":"Levien","year":"2002","journal-title":"The Annals of Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib93","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/2327-6924.12357","article-title":"The role of Toujeo\u00ae, insulin glargine U-300, in the treatment of diabetes mellitus","volume":"28","author":"Brown","year":"2016","journal-title":"Journal of the American Association of Nurse Practitioners"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib94","first-page":"A193","article-title":"Controlling insulin bioavailability by crystal contact engineering","volume":"35","author":"Hilgenfeld","year":"1992","journal-title":"Diabetologia"},{"issue":"9689","key":"10.1016\/j.molmet.2021.101325_bib95","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0140-6736(09)61307-6","article-title":"Insulin glargine and malignancy: an unwarranted alarm","volume":"374","author":"Pocock","year":"2009","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/dc18-0706","article-title":"Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes","volume":"42","author":"Porcellati","year":"2019","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.molmet.2021.101325_bib97","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/bi9625105","article-title":"Crystal structure of a prolonged-acting insulin with albumin-binding properties","volume":"36","author":"Whittingham","year":"1997","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14341\/probl201359456-64","article-title":"Detemir (Levemir): modern paradigms of insulin therapy","volume":"59","author":"Ruiatkina","year":"2013","journal-title":"Problems of Endocrinology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101325_bib99","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41574-021-00498-x","article-title":"Brain insulin signalling in metabolic homeostasis and disease","volume":"17","author":"Scherer","year":"2021","journal-title":"Nature Reviews Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/bi3008609","article-title":"Ligand-controlled assembly of hexamers, dihexamers, and linear multihexamer structures by the engineered acylated insulin degludec","volume":"52","author":"Steensgaard","year":"2013","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/j.molmet.2021.101325_bib101","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"issue":"7","key":"10.1016\/j.molmet.2021.101325_bib102","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cmdc.201700781","article-title":"Glucagon-like peptide-1 (GLP-1)-based therapeutics: current status and future opportunities beyond type 2 diabetes","volume":"13","author":"Cheang","year":"2018","journal-title":"ChemMedChem"},{"issue":"8","key":"10.1016\/j.molmet.2021.101325_bib103","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S2213-8587(21)00113-3","article-title":"Treatment of type 2 diabetes: challenges, hopes, and anticipated successes","volume":"9","author":"Nauck","year":"2021","journal-title":"Lancet Diabetes Endocrinology"},{"key":"10.1016\/j.molmet.2021.101325_bib104","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1021\/acs.jmedchem.1c00257","article-title":"Molecular engineering of insulin Icodec, the first acylated insulin analog for once-weekly administration in humans","volume":"64","author":"Kjeldsen","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"issue":"22","key":"10.1016\/j.molmet.2021.101325_bib105","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2022474","article-title":"Once-weekly insulin for type 2 diabetes without previous insulin treatment","volume":"383","author":"Rosenstock","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molmet.2021.101325_bib106","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-2877","article-title":"Switching to once-weekly insulin Icodec versus once-daily insulin glargine U100 in type 2 diabetes inadequately controlled on daily basal insulin: a phase 2 randomized controlled trial","author":"Bajaj","year":"2021","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.molmet.2021.101325_bib107","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1016\/S0021-9258(17)38396-5","article-title":"Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects","volume":"261","author":"Nakagawa","year":"1986","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib108","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0021-9258(18)52312-7","article-title":"Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions","volume":"266","author":"Mirmira","year":"1991","journal-title":"Journal of Biological Chemistry"},{"issue":"26","key":"10.1016\/j.molmet.2021.101325_bib109","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1021\/bi00192a003","article-title":"High-resolution structure of an engineered biologically potent insulin monomer B16 Tyr\u2192His is, as determined by nuclear magnetic resonance spectroscopy","volume":"33","author":"Ludvigsen","year":"1994","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmbi.1998.1801","article-title":"A\u00a0structural switch in a mutant insulin exposes key residues for receptor binding","volume":"279","author":"Ludvigsen","year":"1998","journal-title":"Journal of Molecular Biology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib111","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.jmedchem.0c01576","article-title":"Engineering of orally available, ultralong-acting insulin analogues: discovery of OI338 and OI320","volume":"64","author":"Kjeldsen","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07388551.2013.834293","article-title":"Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics","volume":"35","author":"Rath","year":"2015","journal-title":"Critical Reviews in Biotechnology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib113","doi-asserted-by":"crossref","first-page":"1800458","DOI":"10.1002\/mabi.201800458","article-title":"A\u00a0review on bioengineering approaches to insulin delivery: a pharmaceutical and engineering perspective","volume":"19","author":"Baghban Taraghdari","year":"2019","journal-title":"Macromolecular Bioscience"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib114","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2337\/db13-0826","article-title":"Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism","volume":"63","author":"Moore","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/dom.12222","article-title":"Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus","volume":"16","author":"Sinha","year":"2014","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib116","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13543784.2017.1274732","article-title":"Discontinued drug therapies to treat diabetes in 2015","volume":"26","author":"Hedrington","year":"2017","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib117","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.yexcr.2011.02.013","article-title":"Introduction to current and future protein therapeutics: a protein engineering perspective","volume":"317","author":"Carter","year":"2011","journal-title":"Experimental Cell Research"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib118","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2174\/0929867324666170113112759","article-title":"Fc-fusion proteins in therapy: an updated view","volume":"24","author":"Jafari","year":"2017","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.molmet.2021.101325_bib119","series-title":"Neonatal Fc receptor and IgG-based therapeutics","first-page":"422","author":"Kuo","year":"2011"},{"issue":"Supplement 1","key":"10.1016\/j.molmet.2021.101325_bib120","doi-asserted-by":"crossref","first-page":"A329","DOI":"10.1210\/jendso\/bvab048.672","article-title":"Basal Insulin FC (BIF), a novel insulin suited for once weekly dosing for the treatment of patients with diabetes mellitus","volume":"5","author":"Heise","year":"2021","journal-title":"Journal of the Endocrine Society"},{"key":"10.1016\/j.molmet.2021.101325_bib121","doi-asserted-by":"crossref","first-page":"108820","DOI":"10.1016\/j.diabres.2021.108820","article-title":"The future of insulin therapy","volume":"175","author":"Heise","year":"2021","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib122","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/dom.13006","article-title":"LAPSInsulin115: a novel ultra-long-acting basal insulin with a unique action profile","volume":"19","author":"Wronkowitz","year":"2017","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.molmet.2021.101325_bib123","doi-asserted-by":"crossref","DOI":"10.1093\/protein\/gzaa026","article-title":"Production of a novel heterodimeric two-chain insulin-Fc fusion protein","volume":"33","author":"Faust","year":"2020","journal-title":"Protein Engineering Design and Selection"},{"issue":"suppl 1","key":"10.1016\/j.molmet.2021.101325_bib124","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.2337\/diabetes.51.2007.S103","article-title":"Physiological consequences of phasic insulin release in the normal animal","volume":"51","author":"Cherrington","year":"2002","journal-title":"Diabetes"},{"issue":"Supplement 1","key":"10.1016\/j.molmet.2021.101325_bib125","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.2337\/diabetes.51.2007.S109","article-title":"Phasic insulin release and metabolic regulation in type 2 diabetes","volume":"51","author":"Del Prato","year":"2002","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib126","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI107697","article-title":"A\u00a0model of the kinetics of insulin in man","volume":"53","author":"Sherwin","year":"1974","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib127","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/152091599317242","article-title":"The Artificial Pancreas Symposium: glucose monitoring, insulin delivery, feedback control","volume":"1","author":"Joseph","year":"1999","journal-title":"Diabetes Technology & Therapeutics"},{"key":"10.1016\/j.molmet.2021.101325_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.06.005","article-title":"Root cause determination of intraperitoneal catheter obstructions: insulin amyloid aggregates vs foreign body reaction","volume":"336","author":"He","year":"2021","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<63::AID-DIA298>3.0.CO;2-F","article-title":"Time\u2013action profile of inhaled insulin","volume":"14","author":"Heinemann","year":"1997","journal-title":"Diabetic Medicine"},{"issue":"8","key":"10.1016\/j.molmet.2021.101325_bib130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinthera.2014.06.025","article-title":"Inhaled insulin: a breath of fresh air? A review of inhaled insulin","volume":"36","author":"Cavaiola","year":"2014","journal-title":"Clinical Therapeutics"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib131","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc15-0075","article-title":"Inhaled technosphere insulin compared with injected prandial insulin in type 1 diabetes: a randomized 24-week trial","volume":"38","author":"Bode","year":"2015","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib132","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.eprac.2020.10.004","article-title":"Ultra rapid-acting inhaled insulin improves glucose control in patients with type 2 diabetes mellitus","volume":"27","author":"Levin","year":"2021","journal-title":"Endocrine Practice"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib133","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00592-014-0557-3","article-title":"Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus","volume":"51","author":"Spaan","year":"2014","journal-title":"Acta Diabetologica"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249611","article-title":"Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: a systematic review and meta-analysis","volume":"16","author":"Dirnena-Fusini","year":"2021","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2005.01672.x","article-title":"Continuous glucose monitoring and closed-loop systems","volume":"23","author":"Hovorka","year":"2006","journal-title":"Diabetic Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2337\/dc09-1080","article-title":"Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas","volume":"33","author":"Renard","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib137","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2337\/dc13-2108","article-title":"Closed-loop artificial pancreas systems: engineering the algorithms","volume":"37","author":"Doyle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2021.101325_bib138","first-page":"1","article-title":"New closed-loop insulin systems","author":"Boughton","year":"2021","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib139","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1073\/pnas.76.1.106","article-title":"Expression in Escherichia coli of chemically synthesized genes for human insulin","volume":"76","author":"Goeddel","year":"1979","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4585","key":"10.1016\/j.molmet.2021.101325_bib140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1126\/science.6337396","article-title":"Human insulin from recombinant DNA technology","volume":"219","author":"Johnson","year":"1983","journal-title":"Science"},{"issue":"6174","key":"10.1016\/j.molmet.2021.101325_bib141","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/333679a0","article-title":"Monomeric insulins obtained by protein engineering and their medical implications","volume":"333","author":"Brange","year":"1988","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib142","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00125-011-2203-8","article-title":"Insulin X10 revisited: a super-mitogenic insulin analogue","volume":"54","author":"Hansen","year":"2011","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034274","article-title":"Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10","volume":"7","author":"Hansen","year":"2012","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.molmet.2021.101325_bib144","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1073\/pnas.84.8.2194","article-title":"A\u00a0mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia","volume":"84","author":"Chan","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"23","key":"10.1016\/j.molmet.2021.101325_bib145","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1073\/pnas.85.23.8943","article-title":"A\u00a0mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway","volume":"85","author":"Carroll","year":"1988","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"18","key":"10.1016\/j.molmet.2021.101325_bib146","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1073\/pnas.84.18.6408","article-title":"A\u00a0superactive insulin:[B10-aspartic acid] insulin (human)","volume":"84","author":"Schwartz","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib147","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/protein\/5.6.527","article-title":"Altering the association properties of insulin by amino acid replacement","volume":"5","author":"Brems","year":"1992","journal-title":"Protein Engineering Design and Selection"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib148","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-008-0974-3","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis","volume":"51","author":"Jeitler","year":"2008","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib149","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/1932296820928100","article-title":"Insulin pump therapy for patients with type 2 diabetes mellitus: evidence, current barriers, and new technologies","volume":"15","author":"Freckmann","year":"2020","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11154-021-09635-3","article-title":"Current treatment options and challenges in patients with Type 1 diabetes: pharmacological, technical advances and future perspectives","volume":"22","author":"Boscari","year":"2021","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib151","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/193229681200600209","article-title":"Intrinsic fibrillation of fast-acting insulin analogs","volume":"6","author":"Woods","year":"2012","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib152","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/193229681200600408","article-title":"A\u00a0review of a family of ultra-rapid-acting insulins: formulation development","volume":"6","author":"Krasner","year":"2012","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib153","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/dom.13963","article-title":"The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications","volume":"22","author":"Owens","year":"2020","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib154","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.xphs.2019.07.025","article-title":"Profiling insulin oligomeric states by 1H NMR spectroscopy for formulation development of ultra-rapid-acting insulin","volume":"109","author":"Falk","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib155","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/dom.14355","article-title":"Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomized, crossover study","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib156","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0969-2126(01)00195-2","article-title":"Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28, ProB29-human insulin","volume":"3","author":"Ciszak","year":"1995","journal-title":"Structure"},{"issue":"33","key":"10.1016\/j.molmet.2021.101325_bib157","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.1021\/bi980807s","article-title":"Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 Pro\u2192Asp insulin analogues","volume":"37","author":"Whittingham","year":"1998","journal-title":"Biochemistry"},{"issue":"6350","key":"10.1016\/j.molmet.2021.101325_bib158","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/354238a0","article-title":"Receptor binding redefined by a structural switch in a mutant human insulin","volume":"354","author":"Hua","year":"1991","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib159","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1006\/jmbi.1996.0648","article-title":"Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue","volume":"264","author":"Hua","year":"1996","journal-title":"Journal of Molecular Biology"},{"issue":"5556","key":"10.1016\/j.molmet.2021.101325_bib160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/261166a0","article-title":"Structure of insulin in 4-zinc insulin","volume":"261","author":"Bentley","year":"1976","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81251-2","article-title":"Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniques","volume":"11","author":"Gillis","year":"2021","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/j.molmet.2021.101325_bib162","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/dom.14368","article-title":"Improved postprandial glucose control with ultra-rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2","volume":"23","author":"Warren","year":"2021","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.molmet.2021.101325_bib163","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1111\/j.1749-6632.2012.06468.x","article-title":"Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering","volume":"1243","author":"Berenson","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib164","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40262-019-00834-5","article-title":"Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences","volume":"59","author":"Haahr","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.molmet.2021.101325_bib165","series-title":"Treprostinil causes local vasodilation, is well tolerated, and results in faster absorption of insulin lispro, (Abstract) American Diabetes Association, 1701 N","first-page":"A253","author":"Pratt","year":"2017"},{"key":"10.1016\/j.molmet.2021.101325_bib166","series-title":"A\u00a0stable, hexameric, ultra-rapid insulin formulation containing citrate (Abstract)","first-page":"A254","author":"Paavola","year":"2017"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib167","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2337\/dc19-2550","article-title":"Randomized double-blind clinical trial comparing Ultra rapid lispro with Lispro in a basal-bolus regimen in patients with type 2 diabetes: PRONTO-T2D","volume":"43","author":"Blevins","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2021.101325_bib168","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s40262-020-00903-0","article-title":"Pharmacokinetics and glucodynamics of ultra rapid lispro (URLi) versus Humalog\u00ae(lispro) in younger adults and elderly patients with type 1 diabetes mellitus: a randomised controlled trial","volume":"59","author":"Linnebjerg","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.molmet.2021.101325_bib169","series-title":"BioChaperone 222 (BC222), the new excipient enabling the ultra-rapid BioChaperone lispro (BCLIS) formulation, is completely absorbed and rapidly excreted after subcutaneous (sc) injection","author":"Meiffren","year":"2018"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib170","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/dom.13621","article-title":"BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: a randomized euglycemic clamp study","volume":"21","author":"Heise","year":"2019","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"550","key":"10.1016\/j.molmet.2021.101325_bib171","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba6676","article-title":"An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients","volume":"12","author":"Mann","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"578","key":"10.1016\/j.molmet.2021.101325_bib172","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd6726","article-title":"Engineering biopharmaceutical formulations to improve diabetes management","volume":"13","author":"Maikawa","year":"2021","journal-title":"Science Translational Medicine"},{"issue":"10","key":"10.1016\/j.molmet.2021.101325_bib173","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nchem.2857","article-title":"Glucose-responsive insulin by molecular and physical design","volume":"9","author":"Bakh","year":"2017","journal-title":"Nature Chemistry"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib174","doi-asserted-by":"crossref","first-page":"1801466","DOI":"10.1002\/adhm.201801466","article-title":"Biologically inspired and chemically derived methods for glucose-responsive insulin therapy","volume":"8","author":"VandenBerg","year":"2019","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/j.molmet.2021.101325_bib175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molmet.2020.101107","article-title":"Glucose-sensitive insulin","volume":"46","author":"Hoeg-Jensen","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"17","key":"10.1016\/j.molmet.2021.101325_bib176","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/anie.199619101","article-title":"Saccharide sensing with molecular receptors based on boronic acid","volume":"35","author":"James","year":"1996","journal-title":"Angewandte Chemie International Edition"},{"issue":"26","key":"10.1016\/j.molmet.2021.101325_bib177","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1016\/S0040-4020(02)00489-1","article-title":"A\u00a0detailed examination of boronic acid\u2013diol complexation","volume":"58","author":"Springsteen","year":"2002","journal-title":"Tetrahedron"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib178","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/psc.624","article-title":"Insulins with built-in glucose sensors for glucose responsive insulin release","volume":"11","author":"Hoeg-Jensen","year":"2005","journal-title":"Journal of Peptide Science"},{"issue":"8","key":"10.1016\/j.molmet.2021.101325_bib179","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1073\/pnas.1424684112","article-title":"Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates","volume":"112","author":"Chou","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.molmet.2021.101325_bib180","series-title":"Glucose-sensitive albumin-binding derivatives. WO Patent Application WO\/2019\/092125","first-page":"2028","author":"Kruse","year":"2020"},{"key":"10.1016\/j.molmet.2021.101325_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2014.01.016","article-title":"Interactions between boric acid derivatives and saccharides in aqueous media: structures and stabilities of resulting esters","volume":"268","author":"Peters","year":"2014","journal-title":"Coordination Chemistry Reviews"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib182","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1039\/C9AN00741E","article-title":"Boronic acid sensors with double recognition sites: a review","volume":"145","author":"Bian","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.molmet.2021.101325_bib183","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2020.02.014","article-title":"Recent progress in design and preparation of glucose-responsive insulin delivery systems","volume":"321","author":"Shen","year":"2020","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib184","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/09205063.2016.1246289","article-title":"Development of shell cross-linked nanoparticles based on boronic acid-related reactions for self-regulated insulin delivery","volume":"28","author":"Wang","year":"2017","journal-title":"Journal of Biomaterials Science, Polymer Edition"},{"issue":"22","key":"10.1016\/j.molmet.2021.101325_bib185","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1073\/pnas.1901967116","article-title":"Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia","volume":"116","author":"Wang","year":"2019","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10.1016\/j.molmet.2021.101325_bib186","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1039\/C9BM01283D","article-title":"A\u00a0forskolin-conjugated insulin analog targeting endogenous glucose-transporter for glucose-responsive insulin delivery","volume":"7","author":"Wang","year":"2019","journal-title":"Biomaterials science"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib187","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/db17-0577","article-title":"Engineering glucose responsiveness into insulin","volume":"67","author":"Kaarsholm","year":"2018","journal-title":"Diabetes"},{"issue":"30","key":"10.1016\/j.molmet.2021.101325_bib188","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103518118","article-title":"Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation","volume":"118","author":"Chen","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"33","key":"10.1016\/j.molmet.2021.101325_bib189","doi-asserted-by":"crossref","first-page":"E3395","DOI":"10.1073\/pnas.1412897111","article-title":"Protective hinge in insulin opens to enable its receptor engagement","volume":"111","author":"Menting","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib190","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/0026-0495(90)90192-F","article-title":"Effects of insulin on glucagon-stimulated glucose production in the conscious dog","volume":"39","author":"Steiner","year":"1990","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib191","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1152\/ajpendo.1991.261.6.E773","article-title":"Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs","volume":"261","author":"Dobbins","year":"1991","journal-title":"American Journal of Physiology - Endocrinology And Metabolism"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib192","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1172\/JCI40919","article-title":"Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs","volume":"120","author":"Rivera","year":"2010","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2021.101325_bib193","doi-asserted-by":"crossref","DOI":"10.2337\/db20-7-LB","article-title":"7-LB: insulin and glucagon coadministration in type 1 diabetes prevents hypoglycemia without worsening hyperglycemia","author":"Bode","year":"2020","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib194","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13657","article-title":"Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats","volume":"6","author":"Pedersen","year":"2018","journal-title":"Physiological reports"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194468","article-title":"Sustained effect of glucagon on body weight and blood glucose: assessed by continuous glucose monitoring in diabetic rats","volume":"13","author":"Pedersen","year":"2018","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.molmet.2021.101325_bib196","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib197","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dbi18-0035","article-title":"Adipose tissue, inter-organ communication, and the path to type 2 diabetes: the 2016 banting medal for scientific achievement lecture","volume":"68","author":"Kahn","year":"2019","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib198","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cmet.2021.03.019","article-title":"Insulin action in adipocytes, adipose remodeling, and systemic effects","volume":"33","author":"Santoro","year":"2021","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib199","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1156804","article-title":"Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics","volume":"4","author":"Shao","year":"2016","journal-title":"Tissue Barriers"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib200","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/dom.12196","article-title":"PEGylated insulin Lispro,(LY2605541)\u2014a new basal insulin analogue","volume":"16","author":"Caparrotta","year":"2014","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.molmet.2021.101325_bib201","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbr.2015.01.003","article-title":"Mechanisms of insulin resistance in the amygdala: influences on food intake","volume":"282","author":"Areias","year":"2015","journal-title":"Behavioural Brain Research"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib202","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12952","article-title":"The regulation of food intake by insulin in the central nervous system","volume":"33","author":"Mitchell","year":"2021","journal-title":"Journal of Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib203","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12966","article-title":"Insulin as a neuroendocrine hormone","volume":"33","author":"Grattan","year":"2021","journal-title":"Journal of Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib204","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12919","article-title":"Insulin signalling in hypothalamic neurones","volume":"33","author":"Belsham","year":"2021","journal-title":"Journal of Neuroendocrinology"},{"issue":"19","key":"10.1016\/j.molmet.2021.101325_bib205","doi-asserted-by":"crossref","first-page":"8748","DOI":"10.1523\/JNEUROSCI.22-19-08748.2002","article-title":"Amygdalo-hypothalamic circuit allows learned cues to override satiety and promote eating","volume":"22","author":"Petrovich","year":"2002","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib206","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2337\/db09-1493","article-title":"Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects","volume":"59","author":"Hallschmid","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2021.101325_bib207","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.diabres.2017.03.032","article-title":"Different impacts of acylated and non-acylated long-acting insulin analogs on neural functions in\u00a0vitro and in\u00a0vivo","volume":"129","author":"Tsuneki","year":"2017","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib208","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13543784.2020.1738383","article-title":"Brain insulin resistance: role in neurodegenerative disease and potential for targeting","volume":"29","author":"H\u00f6lscher","year":"2020","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"14","key":"10.1016\/j.molmet.2021.101325_bib209","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1016\/S0021-9258(18)32085-4","article-title":"Structural differences between insulin receptors in the brain and peripheral target tissues","volume":"258","author":"Heidenreich","year":"1983","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib210","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12959","article-title":"Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease","volume":"33","author":"Ferreira","year":"2021","journal-title":"Journal of Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib211","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.yexcr.2017.04.022","article-title":"Adipose crosstalk with other cell types in health and disease","volume":"360","author":"Choi","year":"2017","journal-title":"Experimental Cell Research"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib212","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2008.07.048","article-title":"Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism","volume":"134","author":"Cao","year":"2008","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib213","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2014.09.035","article-title":"Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects","volume":"159","author":"Yore","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib214","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16: 0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2021.101325_bib215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molmet.2018.12.008","article-title":"The role of C16: 0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach","volume":"21","author":"Raichur","year":"2019","journal-title":"Molecular Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib216","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2020.03.003","article-title":"Impact of GPCR structures on drug discovery","volume":"181","author":"Congreve","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib217","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of \u03b2-arrestin-and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends in Molecular Medicine"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib218","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","article-title":"Teaching old receptors new tricks: biasing seven-transmembrane receptors","volume":"9","author":"Rajagopal","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.molmet.2021.101325_bib219","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fimmu.2020.00300","article-title":"Opioid receptors in immune and glial cells\u2014implications for pain control","volume":"11","author":"Machelska","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"555","key":"10.1016\/j.molmet.2021.101325_bib220","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaq1075","article-title":"Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation","volume":"11","author":"Smith","year":"2018","journal-title":"Science Signaling"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib221","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib222","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-2","article-title":"Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study","volume":"13","author":"Rodr\u00edguez-Flores","year":"2014","journal-title":"Cardiovascular Diabetology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101325_bib223","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1172\/JCI135431","article-title":"Free fatty acid processing diverges in human pathologic insulin resistance conditions","volume":"130","author":"Sekizkardes","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"6865","key":"10.1016\/j.molmet.2021.101325_bib224","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2021.101325_bib225","doi-asserted-by":"crossref","first-page":"600824","DOI":"10.3389\/fonc.2020.600824","article-title":"Type 2 diabetes, obesity, and cancer share some common and critical pathways","volume":"10","author":"Rahman","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101325_bib226","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1073\/pnas.0711713105","article-title":"Dissection of the insulin signaling pathway via quantitative phosphoproteomics","volume":"105","author":"Kr\u00fcger","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/j.molmet.2021.101325_bib227","doi-asserted-by":"crossref","first-page":"140469","DOI":"10.1016\/j.bbapap.2020.140469","article-title":"Application of mass spectrometry based proteomics to understand diabetes: a special focus on interactomics","volume":"1868","author":"Kalita","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics"},{"issue":"25","key":"10.1016\/j.molmet.2021.101325_bib228","doi-asserted-by":"crossref","first-page":"22590","DOI":"10.1074\/jbc.M202119200","article-title":"Peptides identify the critical hotspots involved in the biological activation of the insulin receptor","volume":"277","author":"Pillutla","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib229","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/BJ20080279","article-title":"Activation of the insulin receptor (IR) by insulin and a synthetic peptide has different effects on gene expression in IR-transfected L6 myoblasts","volume":"412","author":"Jensen","year":"2008","journal-title":"Biochemical Journal"},{"issue":"30","key":"10.1016\/j.molmet.2021.101325_bib230","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1074\/jbc.M116.732180","article-title":"Insulin mimetic peptide disrupts the primary binding site of the insulin receptor","volume":"291","author":"Lawrence","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.molmet.2021.101325_bib231","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acscombsci.0c00076","article-title":"Isolation of chemically cyclized peptide binders using yeast surface display","volume":"22","author":"Bacon","year":"2020","journal-title":"ACS Combinatorial Science"},{"issue":"12","key":"10.1016\/j.molmet.2021.101325_bib232","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/acscombsci.0c00179","article-title":"Expanding the chemical diversity of genetically encoded libraries","volume":"22","author":"Iskandar","year":"2020","journal-title":"ACS Combinatorial Science"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib233","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/ijms22041634","article-title":"Screening of yeast display libraries of enzymatically treated peptides to discover macrocyclic peptide ligands","volume":"22","author":"Bowen","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib234","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/acs.biochem.8b01094","article-title":"Display of single-chain insulin-like peptides on a yeast surface","volume":"58","author":"Jeong","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmet.2021.101325_bib235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000111067","article-title":"A\u00a0clinical approach to severe insulin resistance","volume":"11","author":"Savage","year":"2007","journal-title":"Congenital Endocrinopathies"},{"key":"10.1016\/j.molmet.2021.101325_bib236","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.diabres.2018.12.007","article-title":"Concentrated insulins in current clinical practice","volume":"148","author":"Schloot","year":"2019","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.molmet.2021.101325_bib237","first-page":"708183","article-title":"Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations","author":"Sun","year":"2011","journal-title":"Journal of Nutrition and Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib238","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","article-title":"Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use","volume":"49","author":"Kurtzhals","year":"2000","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib239","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib240","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00125-017-4312-5","article-title":"Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study","volume":"60","author":"But","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2021.101325_bib241","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fendo.2013.00098","article-title":"IGF-I, IGF-II, and insulin stimulate different gene expression responses through binding to the IGF-I receptor","volume":"4","author":"Versteyhe","year":"2013","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib242","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-018-0327-4","article-title":"Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?","volume":"10","author":"Moreira","year":"2018","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"6","key":"10.1016\/j.molmet.2021.101325_bib243","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/jc.2018-00070","article-title":"Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial","volume":"103","author":"Rodbard","year":"2018","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101325_bib244","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12325-018-0868-9","article-title":"Optimizing fixed-ratio combination therapy in type 2 diabetes","volume":"36","author":"Perreault","year":"2019","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/2042018817752315","article-title":"A\u00a0review of the new GLP-1 receptor agonist\/basal insulin fixed-ratio combination products","volume":"9","author":"Nuffer","year":"2018","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib246","article-title":"GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: a systematic review and meta-analysis","volume":"35","author":"Castellana","year":"2019","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2021.101325_bib247","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.2337\/dc20-0498","article-title":"Efficacy and safety of short-and long-acting glucagon-like peptide 1 receptor agonists on a background of basal insulin in type 2 diabetes: a meta-analysis","volume":"43","author":"Huthmacher","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.molmet.2021.101325_bib248","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.2337\/dc18-1091","article-title":"Control of postprandial hyperglycemia in type 1 diabetes by 24-hour fixed-dose coadministration of pramlintide and regular human insulin: a randomized, two-way crossover study","volume":"41","author":"Riddle","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib249","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/dci19-0077","article-title":"Rediscovery of the second \u03b2-cell hormone: Co-replacement with pramlintide and insulin in type 1 diabetes","volume":"43","author":"Riddle","year":"2020","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib250","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/dc19-1922","article-title":"A\u00a0novel dual-hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized controlled crossover trial","volume":"43","author":"Haidar","year":"2020","journal-title":"Diabetes Care"},{"issue":"Supplement 1","key":"10.1016\/j.molmet.2021.101325_bib251","doi-asserted-by":"crossref","first-page":"A448","DOI":"10.1210\/jendso\/bvab048.916","article-title":"Once Weekly Basal Insulin Fc (BIF) is safe and efficacious in patients with type 2 diabetes mellitus (T2DM) previously treated with basal insulin","volume":"5","author":"Frias","year":"2021","journal-title":"Journal of the Endocrine Society"},{"issue":"7","key":"10.1016\/j.molmet.2021.101325_bib252","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1037\/a0040388","article-title":"Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice","volume":"71","author":"Gonzalez","year":"2016","journal-title":"American Psychologist"},{"key":"10.1016\/j.molmet.2021.101325_bib253","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/1658-600X.114683","article-title":"Design of ultra-stable insulin analogues for the developing world","volume":"1","author":"Weiss","year":"2013","journal-title":"J.\u00a0Health Spec"},{"issue":"3","key":"10.1016\/j.molmet.2021.101325_bib254","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4103\/ijem.IJEM_211_19","article-title":"Cold chain and insulin: Should we follow the polio vaccine example?","volume":"23","author":"Balachandran","year":"2019","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101325_bib255","doi-asserted-by":"crossref","first-page":"4S51","DOI":"10.1016\/S1262-3636(05)88268-0","article-title":"Weight gain and insulin treatment","volume":"31","author":"Larger","year":"2005","journal-title":"Diabetes and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101325_bib256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0572-9","article-title":"A\u00a0vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease","volume":"16","author":"Chen","year":"2017","journal-title":"Lipids in Health and Disease"},{"issue":"14","key":"10.1016\/j.molmet.2021.101325_bib257","doi-asserted-by":"crossref","first-page":"10806","DOI":"10.1074\/jbc.M109.067850","article-title":"An Achilles' heel in an amyloidogenic protein and its repair: insulin fibrillation and therapeutic design","volume":"285","author":"Yang","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.molmet.2021.101325_bib258","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF01116555","article-title":"The amino acid sequence of human sperm protamine P1","volume":"5","author":"McKay","year":"1985","journal-title":"Bioscience Reports"},{"key":"10.1016\/j.molmet.2021.101325_bib259","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnab020","article-title":"Insulin: a hundred year-old discovery with a fascinating history","author":"Rost\u00e8ne","year":"2021","journal-title":"Endocrine Reviews"},{"issue":"9283","key":"10.1016\/j.molmet.2021.101325_bib260","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(01)05842-1","article-title":"Insulins today and beyond","volume":"358","author":"Owens","year":"2001","journal-title":"The Lancet"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:28:42Z","timestamp":1761956922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821001721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":260,"alternative-id":["S2212877821001721"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101325","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural principles of insulin formulation and analog design: A century of innovation","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101325"}}